Armistice Capital, LLC 13D and 13G filings for Hepion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:07 pm Sale | 2024-09-30 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Armistice Capital, LLC | 304,574 4.990% | -113,426 (-27.14%) | Filing |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Armistice Capital, LLC | 418,000 8.670% | 418,000 (New Position) | Filing |